58 Biggest Movers From Yesterday

Loading...
Loading...

Gainers

  • Madrigal Pharmaceuticals, Inc. MDGL shares surged 144.96 percent to close at $265.61 on Thursday in reaction to an encouraging Phase 2 clinical trial update. The clinical-stage biopharmaceutical company said its liver-directed, thyroid hormone receptor called MGL-3196 showed a statistical significance in the primary endpoint of lowering liver fat at 12 weeks and also 36 weeks.
  • Viking Therapeutics, Inc. VKTX shares rose 101.01 percent to close at $9.99 on Thursday after falling 4.42 percent on Wednesday.
  • Akers Biosciences, Inc. AKER jumped 45.58 percent to close at $0.474. The developer of rapid health information technologies said Wednesday afternoon it was granted a 180-day extension from the Nasdaq Stock Market to meet the requirement of a minimum $1.00 per share closing bid price for 10 straight days.
  • Kitov Pharma Ltd KTOV gained 40.93 percent to close at $3.03 after the FDA approved Kitov's Consensi for the treatment of osteoarthritis pain and hypertension.
  • China Customer Relations Centers, Inc. CCRC rose 28.21 percent to close at $19.86.
  • J.Jill, Inc. JILL climbed 26.45 percent to close at $7.84 after the company posted upbeat quarterly earnings.
  • Curis, Inc. CRIS shares climbed 21.93 percent to close at $2.78 in reaction to an encouraging FDA update. The biotechnology company that focuses on therapies for the treatment of cancer said the FDA granted a Fast Track designation for fimepinostat (CUDC-907) in patients with relapsed or refractory.
  • Boxlight Corporation BOXL gained 21.23 percent to close at $7.48.
  • Kirkland's, Inc. KIRK rose 16.21 percent to close at $12.83 after reporting upbeat Q1 results.
  • The Brink's Company BCO jumped 16.2 percent to close at $79.25 as the company announced plans to acquire Dunbar Armored for $520 million in cash.
  • Applied Optoelectronics, Inc. AAOI rose 15.14 percent to close at $46.77.
  • Takung Art Co., Ltd. TKAT gained 14.28 percent to close at $2.32.
  • OncoCyte Corporation OCX shares climbed 14.04 percent to close at $3.25 on Thursday.
  • LivaNova PLC LIVN rose 13.33 percent to close at $94.05.
  • CymaBay Therapeutics, Inc. CBAY shares rose 12.98 percent to close at $12.97.
  • General Motors Company GM gained 12.87 percent to close at $42.70. The automaker’s autonomous vehicle division secured a $2.25 billion investment from Japan’s SoftBank Vision Fund to be coupled with an additional $1.1 billion investment by GM, itself, according to a Thursday announcement.
  • Tilly's, Inc. TLYS jumped 12.69 percent to close at $13.76 as the company reported better-than-expected earnings for its first quarter and issued a strong Q2 outlook.
  • Safe Bulkers, Inc. SB gained 12.62 percent to close at $3.57.
  • Conatus Pharmaceuticals Inc. CNAT climbed 12.27 percent to close at $4.30.
  • Leap Therapeutics, Inc. LPTX gained 11.91 percent to close at $9.30.
  • Lexicon Pharmaceuticals, Inc. LXRX rose 11.65 percent to close at $11.60 on Thursday.
  • Intelsat S.A. I climbed 11.08 percent to close at $17.85.
  • Keysight Technologies, Inc. KEYS rose 10.85 percent to close at $58.74 following Q2 results.
  • Genprex, Inc. GNPX gained 10.3 percent to close at $10.49. Genprex reported engagement of WIRB-Copernicus Group to provide clinical trial services to support Oncoprex clinical trial program.
  • QAD Inc. QADA shares rose 9.85 percent to close at $51.85.
  • Frontline Ltd. FRO gained 9.54 percent to close at $5.74 after Q1 results beat estimates.
  • Burlington Stores, Inc. BURL gained 7.12 percent to close at $146.25 after the company reported upbeat results for its first quarter and raised its FY18 outlook.
  • vTv Therapeutics Inc. VTVT shares rose 6.91 percent to close at $1.78 after the company reported a licensing deal with Newsoara Biopharma to rights for vTv's PDE4 Inhibitor in China and other Pacific Rim territories.
  • Tech Data Corporation TECD rose 5.35 percent to close at $86.81 following better-than-expected Q1 earnings.

 


Losers

 

  • Clearside Biomedical, Inc. CLSD shares declined 32.19 percent to close at $9.86 on Thursday. Clearside Biomedical disclosed that its Phase 2 trial of CLS-TA met primary and secondary endpoints met in 6-month trial.
  • scPharmaceuticals Inc. SCPH shares dipped 30.1 percent to close at $9.94 on Thursday after the FDA identified deficiencies in the company’s New Drug Application for FUROSCIX. However, the FDA letter did not specify deficiencies identified and notification does not reflect final decision on information under review.
  • Euroseas Ltd. ESEA fell 24.08 percent to close at $1.86. Euroseas announced completion of the spin-off of its drybulk fleet into EuroDry Ltd.
  • Golar LNG Limited GLNG fell 25.09 percent to close at $25.98 following Q1 results.
  • Oragenics, Inc. OGEN shares dropped 25 percent to close at $1.50 on Thursday.
  • Guess', Inc. GES dropped 19.44 percent to close at $19.60 following Q1 results.
  • Cantel Medical Corp. CMD dropped 15.94 percent to close at $109.09 on Thursday following FQ3 results.
  • Fusion Connect, Inc. FSNN shares fell 15.55 percent to close at $3.91.
  • Build-A-Bear Workshop, Inc. BBW dropped 14.44 percent to close at $8.00 after reporting Q1 results.
  • Dollar Tree, Inc. DLTR shares declined 14.28 percent to close at $82.59 after the company reported weaker-than-expected earnings for its first quarter and lowered its FY2018 earnings guidance.
  • Titan Machinery Inc. TITN dropped 13.94 percent to close at $18.09 after reporting Q1 results.
  • Co-Diagnostics, Inc. CODX declined 13.17 percent to close at $2.90 after declining 5.65 percent on Wednesday.
  • Concordia International Corp. CXRX fell 12.89 percent to close at $0.2440 after the company announced that it would be delisted from the Nasdaq.
  • Sears Holdings Corporation SHLD slipped 12.46 percent to close at $2.81 after the company posted a loss for the first quarter and announced plans to close 72 non-profitable stores.
  • Quantum Corporation QTM declined 11.95 percent to close at $3.02. Quantum appointed J. Michael Dodson as Chief Financial Officer and interim CEO, effective May 31. Lake Street downgraded Quantum from Buy to Hold and lowered the price target from $6 to $4.
  • ASLAN Pharmaceuticals Limited ASLN shares fell 10.42 percent to close at $8.25.
  • Aeterna Zentaris Inc. AEZS dropped 9.54 percent to close at $2.37. Aeterna Zentaris named Olaf Althaus as General Manager and Managing Director of Aeterna Zentaris GmbH in Frankfurt, Germany.
  • Cloud Peak Energy Inc. CLD fell 9.5 percent to $3.62.
  • AMERCO UHAL dropped 9.43 percent to close at $322.94 following Q4 results.
  • Dollar General Corporation DG shares declined 9.37 percent to close at $87.48 after reporting weaker-than-expected results for its first quarter.
  • Orchids Paper Products Company TIS fell 9.34 percent to close at $3.98.
  • XOMA Corporation XOMA shares dropped 9.15 percent to close at $21.45.
  • Micron Technology, Inc. MU fell 7.96 percent to close at $57.59. Morgan Stanley downgraded Micron from Overweight to Equal-Weight.
  • Box, Inc. BOX fell 7.56 percent to close at $25.68. Box reported upbeat results for its first quarter. The company forecast Q2 revenue of $146 million to $147 million.
  • Express, Inc. EXPR declined 7.1 percent to close at $8.51 following Q1 results.
  • Merit Medical Systems, Inc. MMSI fell 6.98 percent to close at $51.30. Merit Medical reported the resignation of its CFO Bernard Birkett.
  • CRISPR Therapeutics AG CRSP fell 6.36 percent to close at $68.91 after the company disclosed that the FDA has placed a clinical hold on IND for CTX001 sickle cell disease treatment.
  • Cherry Hill Mortgage Investment Corporation CHMI shares fell 6.26 percent to close at $17.98 after reporting a 2.75 million share common stock offering.
  • Vericel Corp VCEL shares fell 3.58 percent to close at $13.45 following announcement of 3.75 million share common stock offering.
Loading...
Loading...
Posted In: NewsMovers & ShakersPre-Market OutlookMarketsMoversTrading IdeasBiotechnologyHealth CareLosersMovers From YesterdayTop GainersYesterday's Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...